Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Pharma
Orphan Cures Act dropped from Senate reconciliation bill
The Orphan Cures Act would allow drugs with multiple rare disease indications to be exempt from Medicare price negotiations.
Angus Liu
Jun 17, 2025 11:30am
Pharmas to face higher drug rebates in UK in second half of 2025
Jun 11, 2025 11:15am
Pfizer CEO calls for NATO-like drug spending commitments
Jun 10, 2025 11:26am
Large pharmas likely to endure Trump's pricing, tariff threats: S&P
May 28, 2025 11:16am
A Fierce breakdown of the 'most favored nation' executive order
May 16, 2025 9:00am
Consumers remain averse to out-of-pocket GLP-1 costs: KPMG
May 15, 2025 12:01am
